Safety and Efficacy of Add on Modafinil to Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder (original) (raw)

Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy

jeffrey lieberman

Neuropsychopharmacology, 2005

View PDFchevron_right

Fluoxetine versus other types of pharmacotherapy for depression

Laura Rosa Magni

Reviews, 2005

View PDFchevron_right

Emerging targets for antidepressant therapies

charles nemeroff

Current Opinion in Chemical Biology, 2009

View PDFchevron_right

Pharmacological treatment of treatment-resistant depression: Towards evidence-based recommendations

Maja Ivković

Medicinska istraživanja/Medicinska istraživanja, 2024

View PDFchevron_right

An Open-Label Trial of Sertraline for the Treatment of Major Depression in Primary Care

Joaquin Paz

Annals of Clinical Psychiatry, 1999

View PDFchevron_right

Psychotropic Drug Considerations in Depressed Patients with Metabolic Disturbances

M Hasnain

The American Journal of Medicine, 2008

View PDFchevron_right

Selective serotonin re-uptake inhibitors for children and adolescents

Michael Labellarte

European Child & Adolescent Psychiatry, 2000

View PDFchevron_right

Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors

Numan Konuk

Advances in Therapy, 2006

View PDFchevron_right

Effectiveness of fluoxetine 20 mg in the treatment of late life depressive disorders

P. Mesters

Biological Psychiatry, 1997

View PDFchevron_right

Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States

Dima Qato

JAMA, 2018

View PDFchevron_right

Mechanism of Actions of Antidepressants: Beyond the Receptors

Ali Saffet Gonul

Bulletin of Clinical Psychopharmacology

View PDFchevron_right

Plasma serotonin levels are associated with antidepressant response to SSRIs

Owen Wolkowitz

Journal of Affective Disorders, 2019

View PDFchevron_right

Safety and Efficacy of Duloxetine Versus Venlafaxine in Major Depression in Indian Patients

Prem Khosla

2006

View PDFchevron_right

Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness

Boadie Dunlop

Journal of Clinical Psychopharmacology, 2007

View PDFchevron_right

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

Shahin Akhondzadeh

Journal of Clinical Pharmacy and Therapeutics, 2003

View PDFchevron_right

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Martin Härter

BMJ, 2010

View PDFchevron_right

Getting the balance right: Established and emerging therapies for major depressive disorders

Branislav Milovanovic

Neuropsychiatric Disease and Treatment, 2010

View PDFchevron_right

Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder

Shahab Shirkhoda

Iranian Journal of Psychiatry and Behavioral Sciences, 2015

View PDFchevron_right

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment

Albert Maarek

Psychology Research and Behavior Management, 2011

View PDFchevron_right

Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects

Larissa J Maier

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015

View PDFchevron_right

ChemInform Abstract: Prospects for Improved Antidepressants

Dirk Leysen

ChemInform, 2010

View PDFchevron_right

Modafinil Has the Potential for Addiction

Ahmed Mohamed

Ajob Neuroscience, 2012

View PDFchevron_right

Conventional and new antidepressant drugs in the elderly

Pietro Gareri

Progress in Neurobiology, 2000

View PDFchevron_right

Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)

Allan House

BMC Psychiatry, 2013

View PDFchevron_right

A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression

Sun Hwang

American Journal of Psychiatry, 2007

View PDFchevron_right